A multicenter, randomized, open label, parallel study to evaluate and compare the efficacy and safety of FK506MR [tacrolimus] vs Prograf [tacrolimus] in combination with MMF [mycophenolate mofetil] and steroids in patients undergoing kidney transplantation and a pharmacokinetics study

Trial Profile

A multicenter, randomized, open label, parallel study to evaluate and compare the efficacy and safety of FK506MR [tacrolimus] vs Prograf [tacrolimus] in combination with MMF [mycophenolate mofetil] and steroids in patients undergoing kidney transplantation and a pharmacokinetics study

Completed
Phase of Trial: Phase III

Latest Information Update: 26 Feb 2016

At a glance

  • Drugs Methylprednisolone; Mycophenolate mofetil; Prednisolone; Tacrolimus
  • Indications Renal transplant rejection
  • Focus Therapeutic Use
  • Sponsors Astellas Pharma
  • Most Recent Events

    • 10 Mar 2009 Actual initiation date changed from Apr 2007 to Jul 2007 as reported by ClinicalTrials.gov.
    • 10 Mar 2009 Actual end date (Mar 2009) added as reported by ClinicalTrials.gov.
    • 10 Mar 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top